International Clinical Trial: Investigating the Gut Microbiota-Mediated Mechanisms of Spirulina in MAFLD Treatment

Geneva, March 31 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120904) titled 'Investigating the Gut Microbiota-Mediated Mechanisms of Spirulina in MAFLD Treatment' on March 22.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: The Second Affiliated Hospital of Hainan Medical University

Condition: metabolic associated fatty liver disease

Intervention: Moderate Metabolic-Associated Fatty Liver Disease Group:Standard therapy (diet and exercise) Moderate Metabolic-Associated Fatty Liver Disease Group:Standard therapy (diet and exercise)+Spirulina Severe Metabolic-Associated Fatty Liver Disease Group:Standard therapy (diet and exercise)

Recruitment Status: Recrui...